Auto Injectors - Global Market Outlook (2015-2022)

Auto Injectors - Global Market Outlook (2015-2022)

  • Published: June 2016
  • ID: SMRC15742

According to Stratistics MRC, the Global Auto Injectors Market is accounted for $1.10 billion in 2015 and is expected to reach $3.78 billion by 2022 growing at a CAGR of 19.42%. As large number of patients are opting of self administered treatment and care there is a flawless increase in use of Auto Injectors market. Moreover, the high prevailing patients of anaphylaxis had presented a huge demand for the market which seems as pertaining factor behind the market growth. At the same time high cost and need for utmost care are some of the factors dumping the market down at certain period of time.

Prefilled Syringes in primary drug container segment seems to be predominant in market segment because of the dramatic effect on the way injectable drugs are developed, prescribed and administered. Anaphylaxis in the therapeutic application segment will be dominant throughout the forecast period, as more people are allergic and nauseous. While North America being the largest market, Asia pacific hails as fastest growing because of channeling investments into China and India and improving consumer awareness through marketing campaigns.

Some of the major key players of the market are Unilife Corporation, Novartis International AG, Becton, Dickinson and Company, Antares Pharma, Inc., Mylan, Inc., Adamis Pharmaceuticals Corp, Hospira Inc, Scandinavian Health Limited (SHL) Group, Sanofi SA, Itelliject Inc , Pfizer, Inc., Lincoln Medical Ltd, Ypsomed Holdings AG, ALK Abello, Teva Pharmaceuticals Ltd and Biogen Idec, Inc. 

Devices Covered:
• Smart Autoinjectors 
• Product Specific Autoinjectors 
• Manual Injection Autoinjectors 
• Disposable Autoinjectors 
• Reusable Autoinjectors 
• Variable Dose Autoinjectors 
• Automated Injection Autoinjectors

Product Types Covered:
• Standardized Auto-injectors 
• Customized Auto-injectors
Therapeutic Applications covered:
• Autoimmune Diseases 
• Anaphylaxis 
• Anticoagulants 
• Neurology 
• Rheumatoid Arthritis 
• Infectious Diseases 
• Reproductive Health 
• Hormones 
• Hematopoietics 
• Multiple Sclerosis 
• Emergency Medicine 
• Other Therapeutic Application

Primary Drug Containers Covered:   
• Cartridges  
o Single Chamber Cartridge 
o Dual Chamber Cartridge 
• Vials  
• Prefilled Syringes  
o Plastic Prefilled Syringes 
o Glass Prefilled Syringes 

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain  
o Rest of Europe    
• Asia Pacific
o Japan       
o China       
o India       
o Australia       
o New Zealand      
o Rest of Asia Pacific    
•  Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Select License Type

Single User License (PDF)

 

2 - 5 User License (PDF)

 

Corporate License (PDF)

 

Have a Question?


Know our Methodology

WHY CHOOSE US ?

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials